Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
On-demand versus continuous omeprazole use in gastroesophageal reflux disease
NL-OMON41804Phase 4Active, not recruiting
- Sponsor
- Karolinska Institutet
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of omeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Karolinska Institutet. Primary endpoints: Reflux disease questionnaire score, Self-rated health and 1 more. Started May 2015; status: active, not recruiting.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NL-OMON41804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41804.